Effektivnost', bezopasnost' i perspektivy dlitel'nogo ispol'zovaniya tadalafila v rezhime odin raz v den' u patsientov s erektil'noy disfunktsiey


Cite item

Full Text

About the authors

A V Zhivov

Email: andros1@rol.ru

References

  1. Guay A. T. ED2: erectile dysfunction = endothelial dysfunction. Endocrinol. Metab. Clin. N. Am. 2007; 36: 453-465.
  2. Watts G. F., Chew K. K., Stuckey B. G. The erectile-endothelial dysfunction nexus: new opportunities for cardiovascular risk prevention. Nat. Clin. Pract. Cardiovasc. Med. 2007; 4 (5): 263-273.
  3. Braun M., Wassmer G., Klotz T. et al. Epidemiology of erectile dysfunction: Results of the Cologne Male Survey. In. J. Impot. Res. 2000; 12: 305-311.
  4. Ponholzer A., Temml C., Mock K. et al. Prevalence and risk factors for erectile dysfunction in 2869 men using a validated questionnaire. Eur. Urol. 2005; 47: 80-86.
  5. Cialis® (tadalafil) Product Monograph, Eli Lilly Canada Inc. June 25, 2007.
  6. Hanson-Divers C., Jackson S. E., Lue T. F. Health outcomes variables important to patients in the treatment of erectile dysfunction. J. Urol. (Baltimore) 1998; 159: 1541-1547.
  7. Hackett G. I. Patient preferences in treatment of erectile dysfunction: the continuing importance of patient education. Clin. Cornerstone 2005; 7: 57-65.
  8. Leyva M. J. Erectile dysfunction. Perception of sexuality among men who suffer it. Rev. Enferm. 2006; 29: 64-68.
  9. Elia D., Grivel T., Lachowsky M. et al. Erectile dysfunction drugs and women. Gynecol. Obstet. Fertil. 2005; 33: 590-593.
  10. Simonelli C. Men's psychological experience with erectile dysfunction: a multi-ethic survey. In: 2-nd World congress on men's health 2002; October 25-27, 2002 in Vienna, Austria. Vienna; 2002. 53.
  11. Vignozzi L., Filippi S., Morelli A. et al. Effect of chronic tadalafil adminisration on penile hypoxia induced by cavernous neurotomy in the rat. J. Sex. Med. 2006; 3 (3): 419-431.
  12. Heaton J. P. W. The motion: There is a role for chronic treatment with PDE5-inhibitors. Eur. Urol. 2006; 49: 749-753.
  13. McMahon C. G. Treatment of erectile dysfunction with chronic dosing of tadalafil. Eur. Urol. 2006; 50: 215-217.
  14. Hatzimouratidis K., Hatzichristou D. Phosphodiesterase type 5 inhibitors: The day after. Eur. Urol. 2007; 51: 75-89.
  15. McMahon C. Efficacy and safety of daily tadalafil in men with erectile dysfunction previously unresponsive to on-demand tadalafil. J. Sex. Med. 2004; 1: 292-300.
  16. McMahon C. Comparison of efficacy, safety, and tolerability of on-demand tadalafil and daily dosed tadalafil for the treatment of erectile dysfunction. J. Sex. Med. 2005; 2: 415-427.
  17. Forgue S. T., Patterson B. E., Bedding A. W. et al. Tadalafil pharmacokinetics in healthy subjects. Br. J. Clin. Pharmacol. 2006; 61: 280-288.
  18. Porst H., Giuliano F., Glina S. et al. Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5 mg and 10 mg in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial. Eur. Urol. 2006; 50: 351-359.
  19. Patterson B., Bedding A. W., Jewel H. et al. Dose-normalized pharmacokinetics of tadalafil (IC351) administered as a single dose to healthy volunteers. Int. J. Impot. Res. 2001; 13: S63.
  20. Rajfer J., Aliotta P. J., Steidle C. P. et al. Tadalafil dosed once a day in men with erectile dysfunction: A randomized, double-blind, placebo-controlled study in the US. Int. J. Impot. Res. 2007; 19: 95-103.
  21. Hatzichristou D., Gambla M., Rubio-Aurioles E. et al. Efficacy of tadalafil once daily in men with diabetes mellitus and erectile dysfunction. Diabet. Med. 2008; 25: 138-146.
  22. Porst H., Rafjer J., Casabe A. et al. Long-term safety and efficacy of 5 mg tadalafil dosed once daily in men with erectile dysfunction. Presented at he 10-th congress of the European society for sexual medicine; November 25-28, 2007, Lisbon, Portugal.
  23. Aversa A., Greco E., Bruzziches R. et al. Relationship between chronic tadalafil administration and improvement of endothelial function in men with erectile dysfunction: a pilot study. Int. J. Impot. Res. 2007; 19 (2): 200-207.
  24. Lysiak J. J., Yang S. K., Klausner A. P. et al. Tadalafil increases Akt and extracellular signal-regulated kinase 1/2 activation, and prevents apoptotic cell death in the penis following denervation. J. Urol. (Baltimore) 2008; 179 (2): 779-785.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies